Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
Life Sciences and Healthcare Regulatory partner
Lincoln Tsang was featured in a recent The Pink Sheet
article, "Pharma Firms Urged To Push For Post-Brexit
Regulatory Equivalence Deal," which examines the ramifications
of a post-Brexit regulatory equivalence agreement between the UK
and EU on the pharmaceutical industry.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
